- Home
- Publications
- Publication Search
- Publication Details
Title
PharmGKB summary
Authors
Keywords
-
Journal
Pharmacogenetics and Genomics
Volume 22, Issue 2, Pages 159-165
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-10-25
DOI
10.1097/fpc.0b013e32834d4962
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Transcriptional Regulation of the Human CYP2C Genes
- (2012) Yuping Chen et al. CURRENT DRUG METABOLISM
- The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy
- (2011) Paul A. Gurbel et al. AMERICAN HEART JOURNAL
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy
- (2011) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- High Doses of Clopidogrel to Overcome Genetic Resistance
- (2011) Jean-Philippe Collet et al. JACC-Cardiovascular Interventions
- Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events
- (2010) Klaus A. Tiroch et al. AMERICAN HEART JOURNAL
- Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
- (2010) Dirk Sibbing et al. CIRCULATION
- Hepatocyte Nuclear Factor 4 Regulates Rifampicin-Mediated Induction of CYP2C Genes in Primary Cultures of Human Hepatocytes
- (2010) R. Rana et al. DRUG METABOLISM AND DISPOSITION
- Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations
- (2010) Rasmus S. Pedersen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole
- (2010) Barbara Gawrońska-Szklarz et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Linkage disequilibrium between the CYP2C19*17 and CYP2C8*2 alleles in populations of African descent
- (2010) Guilherme Suarez-Kurtz EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genotyping
- (2010) Paul A. Gurbel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
- (2010) Jean-Sébastien Hulot et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2010) Neena S. Abraham et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy
- (2010) D. SIBBING et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The transcription factor GATA-4 regulates cytochrome P4502C19 gene expression
- (2010) Jessica Mwinyi et al. LIFE SCIENCES
- Regulation of CYP2C19 Expression by Estrogen Receptor : Implications for Estrogen-Dependent Inhibition of Drug Metabolism
- (2010) J. Mwinyi et al. MOLECULAR PHARMACOLOGY
- A method and server for predicting damaging missense mutations
- (2010) Ivan A Adzhubei et al. NATURE METHODS
- CYP2C19 variation and citalopram response
- (2010) David A. Mrazek et al. Pharmacogenetics and Genomics
- Characterization of the genetic profile ofCYP2C19in two South African populations
- (2010) Britt I Drögemöller et al. PHARMACOGENOMICS
- Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients
- (2010) A de Vos et al. PHARMACOGENOMICS JOURNAL
- Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
- (2010) F Sofi et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Identification of New CYP2C19 Variants Exhibiting Decreased Enzyme Activity in the Metabolism of S-Mephenytoin and Omeprazole
- (2009) S.-J. Lee et al. DRUG METABOLISM AND DISPOSITION
- Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes
- (2009) Kazuaki Matsumoto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
- (2009) P. Michael Ho JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CYP2C9*1B Promoter Polymorphisms, in Linkage with CYP2C19*2, Affect Phenytoin Autoinduction of Clearance and Maintenance Dose
- (2009) A. S. Chaudhry et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome
- (2009) C. FRÉRE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
- (2009) Prateek Kumar et al. Nature Protocols
- The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients
- (2009) P W Schenk et al. PHARMACOGENOMICS JOURNAL
- Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese
- (2009) Q Zhou et al. PHARMACOGENOMICS JOURNAL
- Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers
- (2008) R. Michael Baldwin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update
- (2008) Edoardo Spina et al. CLINICAL THERAPEUTICS
- Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients
- (2008) I. Rudberg et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects
- (2008) Staffan Ohlsson Rosenborg et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of CYP2C19 Genetic Polymorphisms on the Efficacy of Proton Pump Inhibitor-Based Triple Therapy forHelicobacter pyloriEradication: A Meta-Analysis
- (2008) Fujun Zhao et al. HELICOBACTER
- Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
- (2008) Martine Gilard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
- (2008) Jean-Philippe Collet et al. LANCET
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation
- (2008) Tobias Geisler et al. PHARMACOGENOMICS
- Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample
- (2008) Eric J. Peters et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started